Top Articles

This article will break down some of the laws that a patent carries.

An Over

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

view of Patent Laws

These laws are difficult for a non-lawyer to understand,

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

but not impossible.

The patent laws administered by the Patent and Trademark

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

Office are contained within Title 35 of the United States Code. The USPTO ov

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

rsee the laws dedicated to patents. Title 35 of the United States Code is fur

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

her divided into four parts:

• Title 35 - Part I – provides details on infor

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

mation pertaining to the Patent and Trademark Office, and its role in grantin

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

patents.

• Title 35 – Part II – discusses the ability of the inventions to

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

be patented, along with how patents are granted.

• Title 35 – Part III – inf

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

rmation discussed within this section of the United States Code deals mainly

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ith patent infringement and what rights are available to you as a patent hold

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

er.

• Title 35 – Part IV – can be used to find more specific information per

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

aining to the Patent Cooperation Treaty, and filing a patent internationally.

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

United States Code – Title 35 Part One

This section of the United States C

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

de on patents goes into depth on the role of the Patent Office in administeri

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

g patents to those who qualify. The first four sections of the patent laws st

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

art with an introduction on the role of the Patent Office, and then describe

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

he officers who have been placed in charge of administering patents on behalf

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

of the government. The last section within this section explains how to sear

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

h the Patent Office database, and the fees required for filing an application

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/130699/toparticles-Patent-Laws-Defined-Part-I.html">Patent Laws Defined, Part I</a>

BB link (for phorums):
[url=http://www.toparticles.org.ua/article/130699/toparticles-Patent-Laws-Defined-Part-I.html]Patent Laws Defined, Part I[/url]

Business and Marketing innovation is what drives a company's success – the more competitive the markets get, the more important it is for a business to show and employ creativity. The ultimate proof of Business and Marketing creativity comes under the form of creating breakthrough opportunities and competitive advantages: a Marketing mix that the target market sees as better than the competitor's mix. Among the most successful strategies to achieve a competitive advantage are those operating at market-level, especially market segmentation – the topic to be discussed within this article.

The most basic question any Internet business owner will have to answer at one point or another…”what should I sell?”.

Tags

Links

Top Articles - Patent Laws Defined, Part I

Related Articles: